Storage & Distribution
Storage and distribution is where responsibility for quality leaves the factory without leaving the manufacturer. Good distribution practice — the EU GDP guidelines of 2013, WHO's TRS 957 Annex 5 guidance, and MHRA's interpretation of them — extends the quality system across warehouses, carriers, wholesalers, and borders: product held within its labelled conditions, handled by qualified parties, and traceable at every step. The temperature dimension dominates in practice. Storage areas are mapped so that monitoring reflects reality; transport lanes and packaging solutions are qualified against seasonal extremes; and excursions, when they occur, are assessed against stability data by the quality function rather than waved through by logistics — an excursion is a product-quality event that happens to occur on a motorway.
What this page does not claim
Phases are an organising device, not a regulatory mandate — real programmes overlap them, and a medical device, a food product and a small-molecule drug traverse them differently. Each page says where the differences bite.
What happens in this phase
Storage and distribution is where responsibility for quality leaves the factory without leaving the manufacturer. Good distribution practice — the EU GDP guidelines of 2013, WHO's TRS 957 Annex 5 guidance, and MHRA's interpretation of them — extends the quality system across warehouses, carriers, wholesalers, and borders: product held within its labelled conditions, handled by qualified parties, and traceable at every step. The temperature dimension dominates in practice. Storage areas are mapped so that monitoring reflects reality; transport lanes and packaging solutions are qualified against seasonal extremes; and excursions, when they occur, are assessed against stability data by the quality function rather than waved through by logistics — an excursion is a product-quality event that happens to occur on a motorway.
Supply-chain integrity is the second axis. Distribution is where falsified and diverted product enters legitimate channels, so GDP obliges firms to know their trading partners: supplier and customer qualification, licence verification, and — under the US DSCSA regime — the interoperable, unit-level tracing and verification machinery that lets a returned or suspect unit be checked against its data trail. Imports carry their own layer: the EU's Annex 21 governs importation into the Union, and food operates a structurally similar idea through the foreign-supplier verification programme of 21 CFR 1 subpart L, which makes importers responsible for verifying that offshore suppliers meet domestic preventive-controls standards. Returns, recalls, and withdrawals close the loop — a recall is executed through distribution records, and its speed and precision are a direct function of their quality.
The phase is heavily outsourced — third-party logistics providers, freight forwarders, last-mile carriers — which concentrates quality's work in qualification, agreements, and oversight rather than direct operation. Quality agreements must survive the hard cases: who decides on an excursion at 2 a.m., who owns the data from a carrier's logger, who may re-ice a shipment and under what instruction. Cold-chain and cryogenic products, and increasingly direct-to-patient models in clinical and commercial supply, push qualification effort toward the lane rather than the warehouse. The through-line is custody of evidence: at any moment, for any unit, the organisation should be able to say where it is, what conditions it has seen, and who has touched it — because every downstream decision about that unit depends on those three answers.
- Released product with disposition status enforced by the inventory system — unreleased stock physically and systemically incapable of shipping.
- Mapped, monitored storage areas and qualified transport lanes or packaging solutions appropriate to the product's conditions.
- Qualified trading partners — carriers, wholesalers, 3PLs — under quality agreements with defined excursion and escalation duties.
- Serialisation and tracing connections operating where the destination market requires verification.
- Product delivered within its labelled conditions, with the temperature and custody record to demonstrate it.
- Excursions assessed by quality against stability evidence, with disposition decided before further distribution.
- Traceability maintained to the unit or lot level, sufficient to execute a precise recall.
- Returns dispositioned under pre-defined rules — restocked only when integrity and provenance are demonstrable.
SPEQ synthesis. Phase boundaries and gate criteria are an organising device for planning and review, not a regulatory mandate. Real programmes overlap phases and re-enter them; treat these as the questions worth answering, not a compliance checklist.
- Own excursion disposition: the judgement that connects a lane event to stability data and ends in a documented decision.
- Qualify and oversee storage sites, lanes, and logistics partners, with agreements that allocate the 2 a.m. decisions in advance.
- Operate the recall mechanism — tested periodically, executable in hours, precise to the distribution records' quality.
- Set the returns policy and hold the line on saleable returns, where the falsification risk concentrates.
- Maintain the distribution quality system across licensed activities, including responsible-person duties where jurisdictions require them.
- Temperature mapping studies and continuous monitoring records for storage areas
- Lane and shipping-system qualification evidence against seasonal extremes
- Excursion assessments with stability-based dispositions
- Trading-partner qualification records and quality agreements
- Distribution and traceability records capable of driving a recall
- Recall-readiness test records and, when needed, recall execution files
- Excursion decisions made by logistics under delivery pressure, with quality informed after the product has moved on.
- Lane qualification done once, in spring, for a supply chain that ships through both August and January.
- Stability budget consumed invisibly — repeated small excursions each "accepted" in isolation, with no cumulative accounting.
- Returns restocked on visual inspection alone, which is precisely the door falsified product uses.
- Recall precision limited to "all customers, all lots" because the distribution records cannot say who received what.
Derived from the 6 standards SPEQ maps to this phase, across 5 regulatory bodies: EC, WHO, MHRA, FDA, EMA.
FREQUENTLY ASKED
Who decides what happens after a temperature excursion?
Quality — on evidence, before the product moves further. A defensible excursion process pairs the shipment's actual time-and-temperature record with the product's stability data, asks what fraction of the product's excursion allowance this event consumed, and accounts for what the same units may have seen before. The decision — release, quarantine, reject — is documented with its rationale. Two practices separate mature operations from the rest: the allocation is agreed with logistics partners in advance, so nobody improvises at 2 a.m.; and cumulative exposure is tracked, because five "acceptable" excursions can add up to an unacceptable history.
What does GDP require beyond keeping product cold?
Most of a quality system, applied to a supply chain. GDP covers premises and equipment suitability, personnel and training, documentation and record-keeping, and — centrally — knowing your trading partners: verifying that suppliers are authorised, that customers are entitled to receive, and that transactions are documented well enough to reconstruct the chain. It governs outsourced activities through agreements and audits, requires complaint, return, falsification-suspicion, and recall procedures, and in several jurisdictions demands a named responsible person accountable for the system. Temperature is the visible obligation; supply-chain integrity is the deeper one.
How does distribution differ for food and devices?
The architecture rhymes; the instruments differ. Food supply chains run on preventive controls extended through sanitary-transport rules and, for imports, the foreign-supplier verification programme, which obliges the importer to verify offshore suppliers against domestic standards — traceability is lot-level and recall-driven. Devices lean on the distributor and importer obligations of the EU MDR and on UDI for unit-level identification, with vigilance information flowing back through the same channels product flowed out. Pharmaceuticals remain the most prescriptive regime — licensed wholesalers, responsible persons, unit-level serialisation — but the underlying questions are identical in all three.